Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2012 Jul 1;135(1):201–208. doi: 10.1007/s10549-012-2138-x

Table 2.

Mammary tumor incidence in parous FVB/N mice receiving i.duc PLD

i.duc/duct Tumor
incidencea
P value Tumor type
PLD 40 µg 6/9 0.009 carcinoma, carcinosarcoma
PLD 20 µg 3/7 0.077 carcinoma
PLD 10 µg 3/9 0.206 carcinoma, sarcoma, b LN tumor
Vehicle (50 µl) 0/7 >0.999
No treatment 0/8 Reference
a

The mice were observed for 42 weeks

b

One case of microscopic epithelial tumor in the lymph node (LN) without visible or additional microscopic lesions in the mammary gland sections examined

An exact logistic regression analysis showed there was no change in tumor incidence with a change in PLD dosage (P = 0.449)